Shinpoong's anti-malaria drug to launch phase II studies.

Published: 2005-07-13 06:58:00

Updated: 2005-07-13 06:58:00

Shinpoong announced on July 8 that they conducted a phase II study (a test for effective dose determination) for an anti-malaria drug under the Shipoong's MMV (medicines for malaria venture) project in Thailand, Uganda, Cambodia, Senegal and Zambia

Shinpoong said that the multi-center study aimed at the efficacy and safety determination for the combined drug of pyronaridine and artesunate at...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.